Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.590
-0.009 (-1.50%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $12.63 million as of April 29, 2026. Its market cap has decreased by -8.71% in one year.
Market Cap
12.63M
Enterprise Value
8.14M
1-Year Change
-8.71%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $12.63M, a decrease of -62.17%. That is a compound annual growth rate of -45.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 12.63M | -14.55% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phio Pharmaceuticals | 14.06M |
| Moleculin Biotech | 13.55M |
| Intensity Therapeutics | 13.29M |
| Jupiter Neurosciences | 13.16M |
| BioCardia | 12.69M |
| Cyclerion Therapeutics | 12.38M |
| CDT Equity | 12.10M |
| BioVie | 11.99M |